This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sandeep Sandeep: Innovator in Pharmaceutical Chemistry
Introduction
Sandeep Sandeep is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work is characterized by a focus on improving processes that enhance the efficiency and effectiveness of drug development.
Latest Patents
Sandeep holds a patent for a process related to the preparation of Semaglutide side chain. The patent describes an improved method for synthesizing a compound of Formula (1). This compound is crucial in the synthesis of Semaglutide, a medication used for managing type 2 diabetes. The invention also outlines enhanced processes for preparing intermediates necessary for the synthesis of Formula (1). He has 1 patent to his name.
Career Highlights
Sandeep is currently employed at Fresenius Kabi Oncology Limited, where he applies his expertise in pharmaceutical development. His role involves working on innovative solutions that contribute to the advancement of oncology treatments. His dedication to research and development has positioned him as a valuable asset in his field.
Collaborations
Sandeep collaborates with talented professionals in his workplace, including Saswata Lahiri and Sonu Prasad Shukla. These collaborations foster a creative environment that encourages the exchange of ideas and enhances the quality of their research.
Conclusion
Sandeep Sandeep is a prominent figure in pharmaceutical innovation, with a focus on improving drug synthesis processes. His contributions are vital to the ongoing development of effective treatments in the healthcare industry.